NL192325C - Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting. - Google Patents

Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting. Download PDF

Info

Publication number: NL192325C
Authority: NL; Netherlands
Prior art keywords: caffeine; dihydroergotamine; preparation; nasal; preparation according
Prior art date: 1982-02-01

Application number

NL8300325A

Other languages

English (en)

Dutch (nl)

Other versions

NL8300325A (nl

NL192325B (nl

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-01

Filing date

1983-01-28

Publication date

1997-06-04

1983-01-28 Application filed by Sandoz Ag filed Critical Sandoz Ag

1983-09-01 Publication of NL8300325A publication Critical patent/NL8300325A/nl

1997-02-03 Publication of NL192325B publication Critical patent/NL192325B/xx

1997-06-04 Application granted granted Critical

1997-06-04 Publication of NL192325C publication Critical patent/NL192325C/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NL8300325A 1982-02-01 1983-01-28 Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting. NL192325C (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8202781		1982-02-01
GB8202781		1982-02-01

Publications (3)

Publication Number	Publication Date
NL8300325A NL8300325A (nl)	1983-09-01
NL192325B NL192325B (nl)	1997-02-03
NL192325C true NL192325C (nl)	1997-06-04

Family

ID=10528017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8300325A NL192325C (nl)	1982-02-01	1983-01-28	Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.

Country Status (27)

Country	Link
JP (1)	JPS58134017A (it)
AT (1)	AT385656B (it)
AU (1)	AU565613B2 (it)
BE (1)	BE895750A (it)
CA (1)	CA1197783A (it)
CH (1)	CH653555A5 (it)
DE (1)	DE3302949A1 (it)
DK (1)	DK164771C (it)
ES (1)	ES8502865A1 (it)
FI (1)	FI81258C (it)
FR (1)	FR2539994B1 (it)
GR (1)	GR81320B (it)
HK (1)	HK59989A (it)
HU (1)	HU191512B (it)
IE (1)	IE54532B1 (it)
IL (1)	IL67822A (it)
IT (1)	IT1197558B (it)
KE (1)	KE3888A (it)
LU (1)	LU84613A1 (it)
MY (1)	MY8700766A (it)
NL (1)	NL192325C (it)
NZ (1)	NZ203117A (it)
PH (1)	PH22198A (it)
PT (1)	PT76166B (it)
SE (1)	SE454402B (it)
SG (1)	SG34389G (it)
ZA (1)	ZA83673B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0715285D0 (en) *	2007-08-06	2007-09-12	Britannia Pharmaceuticals Ltd	Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) *	2009-06-16	2009-07-29	Biocopea Ltd	Drug composition and its use in therapy
JP7317020B2 (ja) *	2018-01-05	2023-07-28	インペルファーマシューティカルズインコーポレイテッド	精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3091569A (en) *	1960-08-26	1963-05-28	Mead Johnson & Co	Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) *	1966-12-22	1970-08-19	Sandoz Ltd	Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) *	1976-11-19	1978-06-01	Sandoz Ag	Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) *	1977-04-12	1978-11-10	Cassenne Lab Sa	Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) *	1978-07-19	1982-12-23	Krewel-Werke Gmbh, 5208 Eitorf	Arzneimittel zur Behandlung von Kopfschmerzen

1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU565613B2 (en)	1987-09-24
PT76166B (en)	1986-02-04
SG34389G (en)	1989-09-22
IL67822A0 (en)	1983-06-15
CA1197783A (en)	1985-12-10
FR2539994A1 (fr)	1984-08-03
AU1085083A (en)	1983-08-11
FI830245L (fi)	1983-08-02
JPH0253406B2 (it)	1990-11-16
LU84613A1 (fr)	1983-09-08
HK59989A (en)	1989-08-04
NL8300325A (nl)	1983-09-01
SE454402B (sv)	1988-05-02
JPS58134017A (ja)	1983-08-10
KE3888A (en)	1989-09-01
DK164771B (da)	1992-08-17
IT1197558B (it)	1988-12-06
NZ203117A (en)	1986-12-05
ES519450A0 (es)	1985-02-01
IT8347646A0 (it)	1983-02-01
FR2539994B1 (fr)	1986-10-10
IL67822A (en)	1988-02-29
MY8700766A (en)	1987-12-31
FI81258B (fi)	1990-06-29
DE3302949A1 (de)	1983-08-11
NL192325B (nl)	1997-02-03
AT385656B (de)	1988-05-10
PT76166A (en)	1983-02-01
SE8300495L (sv)	1983-08-02
FI830245A0 (fi)	1983-01-25
IE54532B1 (en)	1989-11-08
ZA83673B (en)	1984-09-26
SE8300495D0 (sv)	1983-01-31
DK38183A (da)	1983-08-02
CH653555A5 (de)	1986-01-15
BE895750A (fr)	1983-08-01
IE830187L (en)	1983-08-01
PH22198A (en)	1988-06-28
DE3302949C2 (it)	1992-05-21
ATA30383A (de)	1987-10-15
DK164771C (da)	1992-12-28
FI81258C (fi)	1990-10-10
HU191512B (en)	1987-02-27
ES8502865A1 (es)	1985-02-01
DK38183D0 (da)	1983-01-31
GR81320B (it)	1984-12-11

Publication	Publication Date	Title
US5169849A (en)	1992-12-08	Nasal pharmaceutical compositions
US11717571B2 (en)	2023-08-08	Intranasal epinephrine formulations and methods for the treatment of disease
RU2421209C2 (ru)	2011-06-20	Фармацевтические композиции, содержащие циклоспорин
KR100361413B1 (ko)	2003-02-19	플루티카손 프로피오네이트 제제
US10751343B2 (en)	2020-08-25	Nasal compositions stimulating ciliary activity
WO1996000071A1 (en)	1996-01-04	Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
IL148241A (en)	2007-02-11	Composition for inhalation containing delta-9-tetrahydrocannabinol
AU2019253137B2 (en)	2025-01-30	Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)
NL192325C (nl)	1997-06-04	Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.
GB2114001A (en)	1983-08-17	Nasal pharmaceutical compositions
AU2021254650B2 (en)	2024-02-22	Intranasal epinephrine formulations and methods for the treatment of disease
JP2025037885A (ja)	2025-03-18	疾患の処置のための鼻腔内エピネフリン製剤及び方法
CN111787954A (zh)	2020-10-16	使用莫美他松和奥洛他定的组合治疗儿科受试者的过敏性鼻炎

Legal Events

Date	Code	Title	Description
1985-01-01	A85	Still pending on 85-01-01
1987-11-02	BA	A request for search or an international-type search has been filed
1987-12-01	BB	A search report has been drawn up
1987-12-01	BC	A request for examination has been filed
1988-07-01	BA	A request for search or an international-type search has been filed
1988-07-01	BB	A search report has been drawn up
1989-06-01	BC	A request for examination has been filed
1997-11-03	SNR	Assignments of patents or rights arising from examined patent applications	Owner name: NOVARTIS AG
2003-04-01	V4	Discontinued because of reaching the maximum lifetime of a patent	Effective date: 20030128